Treatment options for the cutaneous manifestations of systemic sclerosis.
Systemic Sclerosis is a multisystem disorder with vascular instability as a clinical hallmark. Treatment currently consists of recognition and management of end-organ damage. Dermatologists can assist in the management of these patients by facilitating early diagnosis, and treating cutaneous manifestations such as Raynaud's phenomenon, cutaneous calcinosis, and digital ulceration. New potentially disease-modifying therapies are now undergoing clinical trials.
Dutz
J
J
Divisions of Dermatology and Rheumatology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
D006801:Humans; D012595:Scleroderma, Systemic / Q000188:drug therapy*